Showing 40,021 - 40,040 results of 104,689 for search '(( 5 ((((a decrease) OR (nn decrease))) OR (mean decrease)) ) OR ( 2 fold decrease ))', query time: 1.65s Refine Results
  1. 40021
  2. 40022
  3. 40023
  4. 40024

    RAINFALL REGIME ON FINE ROOT GROWTH IN A SEASONALLY DRY TROPICAL FOREST by EUNICE MAIA DE ANDRADE (4894216)

    Published 2021
    “…The fine root biomass in July 2015 was 7.7±5.0 Mg ha-1 and the length was 5.0±3.2 km m-2. …”
  5. 40025

    DataSheet1_A ROCK1 Inhibitior Fasudil Alleviates Cardiomyocyte Apoptosis in Diabetic Cardiomyopathy by Inhibiting Mitochondrial Fission in a Type 2 Diabetes Mouse Model.docx by Xinhui Fan (8496873)

    Published 2022
    “…ROCK1 (rho-associated coiled-coil containing protein kinase 1) serves as a pathological factor in several diabetic complications. …”
  6. 40026

    Age-Related Decline of Neutrophilic Inflammation Is Associated with Better Postoperative Prognosis in Non-eosinophilic Nasal Polyps by Dae Woo Kim (652481)

    Published 2016
    “…Tissue samples were analyzed for protein levels of IL-5, IL-17A, IL-23, interferon (IFN)-γ, CCL-11, and CXCL-8, using Luminex immunoassay and for mRNA expression levels of interleukin (IL)-5, IL-17A, IL-23p19, IFN-γ, CCL-11, CXCL-1, CXCL-2, CXCL-8, and CXCR2 by quantitative RT-PCR. …”
  7. 40027

    Hyper-Hypo study: A Retrospective Observational Study of Neonatal Hypoglycemia Related to Maternal Hypertension by Thiruveni Ramkumar (17075051)

    Published 2023
    “…However, a sub-group comparison of neonates (with initial blood glucose <2.6 mmol/L) showed methyldopa to be marginally associated with a 2 mmol/L decrease from the mean initial blood glucose, mean 1.6 ± 0.5 mmol/L, and methyldopa (1.4 ± 0.5 mmol/L; p= .045). …”
  8. 40028

    Table_2_Is periodontal disease a risk indicator for urogenital cancer? A systematic review and meta-analysis of cohort studies.docx by Weiqi Li (419558)

    Published 2022
    “…Our results suggest that PD patients increases the risk of UC by 1.24-fold (hazard ratio (HR), 1.24; 95% CI, 1.17-1.31; I<sup>2</sup>, 22.4%). …”
  9. 40029
  10. 40030

    Benefits of Therapeutic Drug Monitoring of Vancomycin: A Systematic Review and Meta-Analysis by Zhi-Kang Ye (474245)

    Published 2013
    “…Compared with non-TDM groups, TDM groups had significantly higher rates of clinical efficacy (OR = 2.62, 95%CI 1.34–5.11 P = 0.005) and decreased rates of nephrotoxicity (OR = 0.25, 95%CI 0.13–0.48 P<0.0001). …”
  11. 40031
  12. 40032
  13. 40033
  14. 40034
  15. 40035
  16. 40036
  17. 40037
  18. 40038
  19. 40039
  20. 40040